Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |